Our findings suggest a significant association between air pollutants and the development of NSCLC and propose potential biomarkers for enhanced diagnostic accuracy, alongside potential therapeutic targets. Future research should prioritize the clinical validation of these findings and the investigation of targeted therapies that consider environmental risk factors, thereby enhancing NSCLC management strategies and patient outcomes.